Skip to main content
. 2013 Oct 5;11:246. doi: 10.1186/1479-5876-11-246

Figure 1.

Figure 1

Antibody responses to recombinant NY-ESO-1 protein as determined by ELISA. Sera from 13 patients in Cohort 1 (100-μg dose) and 12 patients in Cohort 2 (200-μg dose) were collected at each vaccination, and serially diluted by 400, 1,600, 6,400, 25,600 and 102,400. Reciprocal titers were determined based on the maximally diluted sera, which showed a higher OD (optical density of 450–500) value than the cut-off level for NY-ESO-1 antibody positivity.